Zhu Y, Lu Y, Zhu Y, Ren X, Deng Q, Yang M
Sci Rep. 2024; 14(1):26393.
PMID: 39488565
PMC: 11531471.
DOI: 10.1038/s41598-024-76763-6.
Di Carmine S, Scott M, McLean M, McSorley H
Discov Immunol. 2024; 1(1):kyac006.
PMID: 38566909
PMC: 10917208.
DOI: 10.1093/discim/kyac006.
Chigbu D, Karbach N, Abu S, Hehar N
Life (Basel). 2024; 14(3).
PMID: 38541674
PMC: 10971254.
DOI: 10.3390/life14030350.
Chatterjee A, Azevedo-Martins J, Stachler M
Onco Targets Ther. 2023; 16:675-687.
PMID: 37583706
PMC: 10424681.
DOI: 10.2147/OTT.S389120.
Yaluri N, Yaluri A, Zenuch P, Zenuchova Z, Toth S, Kalanin P
Diagnostics (Basel). 2023; 13(15).
PMID: 37568870
PMC: 10417576.
DOI: 10.3390/diagnostics13152508.
Interleukin-33 Potentiates TGF-β Signaling to Regulate Intestinal Stem Cell Regeneration After Radiation Injury.
Guan R, Pan M, Xu X, Du L, Rao X, Fu G
Cell Transplant. 2023; 32:9636897231177377.
PMID: 37291802
PMC: 10272662.
DOI: 10.1177/09636897231177377.
Knowledge mapping and research trends of IL-33 from 2004 to 2022: a bibliometric analysis.
Jin J, Wan Y, Shu Q, Liu J, Lai D
Front Immunol. 2023; 14:1158323.
PMID: 37153553
PMC: 10157155.
DOI: 10.3389/fimmu.2023.1158323.
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges.
Balakrishnan B, Kulkarni U, Pai A, Stallon Illangeswaran R, Mohanan E, Mathews V
Front Immunol. 2023; 14:1100306.
PMID: 36817455
PMC: 9932777.
DOI: 10.3389/fimmu.2023.1100306.
The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
Lei S, Jin J, Zhao X, Zhou L, Qi G, Yang J
Exp Biol Med (Maywood). 2022; 247(20):1810-1818.
PMID: 35733343
PMC: 9679353.
DOI: 10.1177/15353702221102094.
Alarmin Cytokines as Central Regulators of Cutaneous Immunity.
Hasegawa T, Oka T, Demehri S
Front Immunol. 2022; 13:876515.
PMID: 35432341
PMC: 9005840.
DOI: 10.3389/fimmu.2022.876515.
The Role of Airway Epithelial Cell Alarmins in Asthma.
Whetstone C, Ranjbar M, Omer H, Cusack R, Gauvreau G
Cells. 2022; 11(7).
PMID: 35406669
PMC: 8997824.
DOI: 10.3390/cells11071105.
Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review.
Sarrand J, Soyfoo M
Int J Mol Sci. 2022; 23(6).
PMID: 35328556
PMC: 8949418.
DOI: 10.3390/ijms23063138.
Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential.
Huang F, Chen W, Ma J, He X, Wang J
World J Clin Cases. 2022; 10(1):23-34.
PMID: 35071502
PMC: 8727260.
DOI: 10.12998/wjcc.v10.i1.23.
IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
Cayrol C
Cells. 2022; 11(1).
PMID: 35011670
PMC: 8750818.
DOI: 10.3390/cells11010107.
The Paradigm Change of IL-33 in Vascular Biology.
Demyanets S, Stojkovic S, Huber K, Wojta J
Int J Mol Sci. 2021; 22(24).
PMID: 34948083
PMC: 8707059.
DOI: 10.3390/ijms222413288.
IL-33 in Rheumatic Diseases.
Dong Y, Zhong J, Dong L
Front Med (Lausanne). 2021; 8:739489.
PMID: 34589505
PMC: 8473687.
DOI: 10.3389/fmed.2021.739489.
Biomarkers in Acute Heart Failure Syndromes: An Update.
Al-Sadawi M, Saad M, Ayyadurai P, Shah N, Bhandari M, Vittorio T
Curr Cardiol Rev. 2021; 18(3):e090921196330.
PMID: 34503430
PMC: 9615213.
DOI: 10.2174/1573403X17666210909170415.
A possible role for ST2 as prognostic biomarker for COVID-19.
Ragusa R, Basta G, Del Turco S, Caselli C
Vascul Pharmacol. 2021; 138:106857.
PMID: 33746068
PMC: 7970796.
DOI: 10.1016/j.vph.2021.106857.
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
Kumar V
Int Immunopharmacol. 2020; 89(Pt B):107087.
PMID: 33075714
PMC: 7550173.
DOI: 10.1016/j.intimp.2020.107087.
Altered behavior in mice overexpressing soluble ST2.
Kikuchi M, Takase K, Hayakawa M, Hayakawa H, Tominaga S, Ohmori T
Mol Brain. 2020; 13(1):74.
PMID: 32393354
PMC: 7216579.
DOI: 10.1186/s13041-020-00606-4.